🇺🇸 Triphasil in United States
166 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 166
Most-reported reactions
- Anxiety — 25 reports (15.06%)
- Depression — 23 reports (13.86%)
- Headache — 19 reports (11.45%)
- Nausea — 17 reports (10.24%)
- Drug Ineffective — 16 reports (9.64%)
- Dyspnoea — 15 reports (9.04%)
- Fatigue — 14 reports (8.43%)
- Unintended Pregnancy — 13 reports (7.83%)
- Dizziness — 12 reports (7.23%)
- Pulmonary Embolism — 12 reports (7.23%)
Other Other approved in United States
Frequently asked questions
Is Triphasil approved in United States?
Triphasil does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Triphasil in United States?
Desmond Tutu HIV Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.